Becton, Dickinson and Company Announces Retirement of Interventional Segment President

Key Developments

• Retirement Announcement:
  On April 6, 2026, Becton, Dickinson and Company (“BD”) announced that Rick Byrd, Executive Vice President and President of the Interventional segment, has informed the company of his intention to retire. Mr. Byrd will remain in his current role through June 2026, ensuring a smooth transition.
• Succession Plan:
  BD intends to name a successor prior to Mr. Byrd’s retirement date, indicating the company’s commitment to leadership continuity in this key business segment.
• Press Release Issued:
  On April 9, 2026, BD issued a press release related to the leadership changes. The company noted that the press release is attached as Exhibit 99.1 in their SEC filing.

Details for Investors

• Leadership Change in a Critical Segment:
  The Interventional segment is one of BD’s major business units, and the retirement of its President could signal shifts in operational strategies or leadership style. Shareholders should monitor for further announcements, especially regarding the appointment of the new segment leader and any potential strategic redirection.
• Potential Impact on Share Price:
  While executive retirements are not uncommon, changes at the top of a key business unit can affect investor sentiment, especially if the market perceives uncertainty about future leadership or strategy. The market may react based on the reputation and track record of Mr. Byrd’s successor once announced.
• No Immediate Impact on Reporting:
  The company has stated that the information related to the retirement and press release is being furnished, not filed, under SEC rules—meaning it is not considered part of the formal record for liability purposes. This is standard for Regulation FD disclosures but is still material information for investors.
• Other Material Information:
  No other significant, potentially price-sensitive disclosures were included in the filing. There are no indications of changes to BD’s financial guidance, operations, or other strategic shifts outside this leadership change.

BD’s Listed Securities

For reference, BD’s registered securities traded on the New York Stock Exchange include:

• Common stock (Ticker: BDX)
• 1.900% Notes due December 15, 2026 (Ticker: BDX26)
• 1.208% Notes due June 4, 2026 (Ticker: BDX/26A)
• 1.213% Notes due February 12, 2036 (Ticker: BDX/36)
• 3.519% Notes due February 8, 2031 (Ticker: BDX31)
• 3.828% Notes due June 7, 2032 (Ticker: BDX32A)

What Should Shareholders Watch For?

• Announcement of Successor: The identity, background, and strategic vision of the new President of the Interventional segment will be critical for assessing any changes to BD’s growth trajectory in this business.
• Market Reaction: Investors and analysts will likely scrutinize upcoming communications for indications of strategic change, potential impact on business operations, and any shifts in BD’s competitive positioning in the interventional space.
• Further Disclosures: Watch for any updates in subsequent filings or earnings calls regarding the leadership transition and potential impacts on BD’s broader business objectives.

Contacts

Media: Megan Dubrowski, Senior Director, Executive Communications – [email protected]
Investors: Shawn Bevec, SVP, Investor Relations – [email protected]

Disclaimer: This article is based on public disclosures by Becton, Dickinson and Company filed with the Securities and Exchange Commission as of April 2026. The information herein is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making investment decisions. The company has not provided any financial guidance or material operational updates in this filing other than the leadership change described above.

View BECTON DICKINSON & CO Historical chart here